Jing Yuan

Title: The Innovative Contributions of Jing Yuan

Introduction

Jing Yuan is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of non-Hodgkin's lymphoma. His innovative approach has led to the development of a unique therapeutic agent that holds promise for patients suffering from this type of cancer.

Latest Patents

Jing Yuan holds a patent for the "Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma." This patent discloses the use of a liposomal pharmaceutical preparation of mitoxantrone in the preparation of a medicament specifically for treating lymphoma. The focus is on non-Hodgkin's lymphoma, particularly aggressive forms such as diffuse large B-cell lymphoma or peripheral T-cell lymphoma. The invention emphasizes the use of mitoxantrone liposomes as a single anti-tumor therapeutic agent, without the need for combination with other anti-tumor agents. He has 1 patent to his name.

Career Highlights

Jing Yuan is currently associated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His work at this company has been instrumental in advancing pharmaceutical technologies and improving treatment options for cancer patients. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Jing Yuan has collaborated with several professionals in his field, including Chunlei Li and Yueying Peng. These collaborations have fostered a productive environment for innovation and have contributed to the success of his projects.

Conclusion

Jing Yuan's contributions to the field of pharmaceuticals, particularly in the treatment of non-Hodgkin's lymphoma, highlight his innovative spirit and commitment to improving patient outcomes. His work continues to inspire advancements in cancer treatment.